{"id":"NCT01631110","sponsor":"Crucell Holland BV","briefTitle":"Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains","officialTitle":"Open, Non-randomized Trial to Assess the Immunogenicity and Safety of the 2012/2013-Season Influenza Vaccine in Elderly and Young Subjects According to EMA Regulations","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-07","primaryCompletion":"2012-08","completion":"2012-08","firstPosted":"2012-06-28","resultsPosted":"2013-12-20","lastUpdate":"2013-12-20"},"enrollment":110,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Inflexal V","otherNames":["Inflexal V influenza vaccine (surface antigen, inactivated, virosome) formulated for the WHO requirements of the 2012-2013 season, each 0.5 mL dose containing:","• 15 µg HA antigen of A/California/7/2009 (H1N1)-like virus","• 15 µg HA antigen of A/Victoria/361/2011 (H3N2)-like virus","• 15 µg HA antigen of B/Wisconsin/1/2010-like virus"]}],"arms":[{"label":"Elderly subjects aged over 60 years","type":"EXPERIMENTAL"},{"label":"Adults from 18 to 60 years old inclusive","type":"EXPERIMENTAL"}],"summary":"The study is to assess whether the influenza vaccine Inflexal V for season 2012/2013 fulfills the EMA requirements for re-registration of influenza vaccines.","primaryOutcome":{"measure":"Seroprotection","timeFrame":"Day 22 +/- 2 days","effectByArm":[{"arm":"Elderly Subjects Aged Over 60 Years","deltaMin":65.5,"sd":null},{"arm":"Adults From 18 to 60 Years Old Inclusive","deltaMin":80,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":15},"locations":{"siteCount":1,"countries":["Switzerland"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":55},"commonTop":["Injection site pain","Injection site erythema","Injection site induration","Headache","Injection site haemorrhage"]}}